| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0760362B1 diaminomethylidene derivative |
| 08/14/2002 | DE10106147A1 Saure Pigmentdispergatoren und Pigmentzubereitungen Acidic pigment dispersants and pigment preparations |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432948 Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060868A2 Inhibitors of prenyl-protein transferase |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2001077134A3 Process for the preparation of 6-o-propargyl erythromycin derivatives |
| 08/08/2002 | US20020107189 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2426684A1 Inhibitors of prenyl-protein transferase |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1025107B1 Photochromic compounds |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/01/2002 | WO2002059129A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059116A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002011766A3 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 08/01/2002 | US20020103373 Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 08/01/2002 | US20020103170 Oxazinoquinolones useful for the treatment of viral infections |
| 08/01/2002 | US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2424402A1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 07/31/2002 | EP1227103A2 Ring-expanded nucleosides and nucleotides |
| 07/31/2002 | EP1227097A1 Ucs1025 derivatives |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | CN1361781A Oxazinocarbazoles for the treatment of CNS diseases |
| 07/31/2002 | CN1361691A New use of a macrolide compound |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2001036048A9 Phorboxazole derivatives for treating cancer |
| 07/25/2002 | US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 07/25/2002 | US20020099074 Novel anilide compounds and drugs containing the same |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/24/2002 | EP1224189A2 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 07/24/2002 | EP1025108B1 Photochromic spiro(indoline) fluoranthenoxazine compounds |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0820454B1 Anellated beta-carbolines |
| 07/24/2002 | EP0785936B1 Photochromic naphthoxazine compounds |
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1088068C Ascomycins |
| 07/23/2002 | US6423843 Microbiocides |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423722 Antiinflammatory agents |
| 07/18/2002 | WO2002004409A3 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222165A2 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| 07/17/2002 | CN1359378A 2-oxy-benzoxazine derivatives for the treatment of obesity |
| 07/17/2002 | CN1358724A Improved process for rifa high-density raw powder I type crystal |
| 07/16/2002 | US6420461 Compounds based on polyalkyl-1-oxadiazaspirodecane compounds |
| 07/11/2002 | WO2002053568A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 07/11/2002 | WO2001022919A3 Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| 07/11/2002 | US20020091258 Low solubility, good fastness, red to blue colorations; use pigmenting paints, plastics, printing inks, pigment preparations, electrophotographic toners and developers, powder coating, inkjet inks, color filters and cosmetics |
| 07/11/2002 | US20020091137 Use of CCI-779 as an antineoplastic agent |
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | CN1358186A Tricyclic benzoylcylohexanedione derivatives |
| 07/10/2002 | CN1357548A Process for production of levo-ofloxacin |
| 07/10/2002 | CN1357547A Prepn. of levo-ofloxacin |
| 07/09/2002 | US6417195 Isoquinoline derivatives and isoquinoline combinatorial libraries |
| 07/09/2002 | US6417193 Methods for inhibiting MRP1 |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051413A2 Macrocyclic anti-viral compounds |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
| 07/02/2002 | US6414149 Treating diabetes, treating or preventing diabetic complications |
| 07/02/2002 | US6414142 Concurrently adding solution of potassium 2-ethyl hexanoate in isopropanol and solution of tertiary-butylamino clavulanate in aqueous isopropanol to mixture of isopropanol and acetone, precipitating potassium clavulanate as rosette-like starbursts |
| 07/02/2002 | US6414057 Stress resistance, dyeable |
| 07/02/2002 | US6413983 Coupling epoxide with indole or quinoline compound; protect-ing heart, brain, retina and neuronal cell from ?ischemia-reperfusion? injury; suppressing lipid peroxidation |
| 07/02/2002 | US6413981 Drug-resistant gram positive and gram negative bacteria; pneumonia; infections of upper and lower respiratory tract, skin, soft tissue, bones and joints |
| 07/02/2002 | US6413964 14-amino-14-(1-methyl-1h-imidazol-5-yl)-8-oxa-2-thia-1,18 -diazatetracyclo(16.2.2.1(3,7).1(9,13))tetracosa-3(24),4,6, 9(23),10,12-hexaene-10-carbonitrile 2,2-dioxide, for example; use in radiotherapy, chemotherapy as sensitizer |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 06/27/2002 | WO2002050084A2 Streptogramin derivatives preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050083A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050080A1 Small molecules useful in the treatment of inflammatory disease |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002008231A3 Biologically active macrolides, compositions, and uses thereof |
| 06/27/2002 | US20020082302 Reacting tetrahydrofuan-imidazoline compound with metal organic derivative of 1-(3-R1-4-R2-phen-1-yl)- 2-R3-3-halogen propanes; removal of the pseudoephedrine protecting group and -OH group, reaction with amine and removal of protecting group |
| 06/27/2002 | US20020082270 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases |
| 06/27/2002 | US20020082174 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |